CAS RN: 52423-70-8
2-(3-(4-Chlorophenyl)pyrrolidin-3-yl)ethanol
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250307
25mg / 100mg / 250mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 52423-70-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
52423-70-8 / 2-[3-(4-chlorophenyl)pyrrolidin-3-yl]ethanol
Standard CAS: 52423-70-8
Multi CAS: No
Basic Information
copy
CAS
52423-70-8 copy
Multi CAS
No copy
Molecular Formula
C12H16CLNO copy
Molecular Weight
225.710000 copy
Exact Mass
225.092042 copy
InChI
InChI=1S/C12H16ClNO/c13-11-3-1-10(2-4-11)12(6-8-15)5-7-14-9-12/h1-4,14-15H,5-9H2 copy
InChIKey
ILTULPUUFNFODT-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
3 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
62.32 copy
TPSA
32.26 copy
LogP / Solubility
WLOGP
1.95 copy
MLOGP
1.72 copy
XLogP3
2 copy
Consensus LogP
1.89 copy
Log S (ESOL)
-2.57 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.82 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-3.11 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.71 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy